Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Vandana Batra"'
Publikováno v:
iScience, Vol 27, Iss 2, Pp 108920- (2024)
Summary: Rapid industrialization and untreated industrial effluents loaded with toxic and carcinogenic contaminants, especially dyes that discharge into environmental waters, have led to a rise in water pollution, with a substantial adverse impact on
Externí odkaz:
https://doaj.org/article/92b733cdd5694141b1acc77a3b791a6b
Autor:
Mehran Makvandi, Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel, David Groff, Jennifer Pogoriler, Daniel Martinez, Aladdin Riad, Hannah Dabagian, Michael Zaleski, Tara Taghvaee, Kuiying Xu, Ji Youn Lee, Catherine Hou, Alvin Farrel, Vandana Batra, Sean D. Carlin, Daniel J. Powell, Robert H. Mach, Daniel A. Pryma, John M. Maris
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-9 (2022)
The efficacy and toxicity of the PARP inhibitor parthanatine, radiolabeled with the alpha particle emitter astatine-211, in 11 patient derived neuroblastoma murine xenografts is investigated.
Externí odkaz:
https://doaj.org/article/39307010894b498daf099e0526685b72
Publikováno v:
Applied Surface Science Advances, Vol 11, Iss , Pp 100314- (2022)
Organic pollutants in industrial waste must be handled with viable and eco-friendly approaches. In particular, releasing toxic effluents like dyes into the environment pollutes water bodies, causing fatal diseases in humans and is hazardous to aquati
Externí odkaz:
https://doaj.org/article/7609e3c5347c4d71a0fa8d09a8b85105
Autor:
Simei Darinel Torres Landa, Naveen Kumar Reddy Bogireddy, Inderbir Kaur, Vandana Batra, Vivechana Agarwal
Publikováno v:
iScience, Vol 25, Iss 2, Pp 103816- (2022)
Summary: The discovery of carbon dots (CDs) for environmental remediation has gained awareness because of the diverse economically viable and environmental friendly green precursors generated from biowastes and biomass compared to the toxic inorganic
Externí odkaz:
https://doaj.org/article/0617cae731f046db9322a97379a61a9b
Publikováno v:
International Journal of Scientific and Research Publications. 13:120-127
Publikováno v:
Materials Today: Proceedings. 73:312-315
Autor:
Micky K. Bacchus, David S. Anderson, Esther R. Berko, Lisa J. States, Rochelle Bagatell, Sarah E. Hopkins, Vandana Batra
Publikováno v:
Journal of Pediatric Hematology/Oncology. 45:152-154
Autor:
John M. Maris, Giordano Caponigro, Malte Peters, Markus Boehm, Shiva Krupa, Kristina A. Cole, Scott Delach, Sudha Parasuraman, Sunkyu Kim, Andrew Wood, Yimei Li, Daniel Martinez, Lucy Chen, Maria Gagliardi, Matthew Tsang, Mike R. Russell, Vandana Batra, Pichai Raman, JulieAnn Rader, Lori S. Hart
Supplementary Figure S1. Neuroblastoma cell lines are sensitive to binimetinib. Supplementary Figure S2. Gene expression profiling of human neuroblastoma cell lines with regards to relative sensitivity to MEK1/2 and CDK4/6 inhibition Supplementary Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e2ea30d64011bd557c761378aa7b1d9
https://doi.org/10.1158/1078-0432.22462743.v1
https://doi.org/10.1158/1078-0432.22462743.v1
Autor:
John M. Maris, Daniel A. Pryma, Sean Carlin, Ganesan Vaidyanathan, Daniel Martinez, Bruce Pawel, Yimei Li, Catherine Hou, Matthew Tsang, Pietro Ranieri, Jimmy Elias, Paul Martorano, David Groff, Mehran Makvandi, Minu Samanta, Vandana Batra
Purpose:[131I]meta-iodobenzylguanidine ([131I]MIBG) is a targeted radiotherapeutic administered systemically to deliver beta particle radiation in neuroblastoma. However, relapses in the bone marrow are common. [211At]meta-astatobenzylguanidine ([211
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cc1c9bf50632e98d2452ab3ac3bd71
https://doi.org/10.1158/1078-0432.c.6532614
https://doi.org/10.1158/1078-0432.c.6532614
Autor:
John M. Maris, Daniel A. Pryma, Sean Carlin, Ganesan Vaidyanathan, Daniel Martinez, Bruce Pawel, Yimei Li, Catherine Hou, Matthew Tsang, Pietro Ranieri, Jimmy Elias, Paul Martorano, David Groff, Mehran Makvandi, Minu Samanta, Vandana Batra
Supplementary Figure from Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0568e7c11fe402fb613e7a36b04b29c2
https://doi.org/10.1158/1078-0432.22487925.v1
https://doi.org/10.1158/1078-0432.22487925.v1